Log In
BCIQ
Print this Print this
 

Vx-006

  Manage Alerts
Collapse Summary General Information
Company Vaxon Biotech
DescriptionVaccine containing optimized cryptic polypeptide which targets three peptides in major histocompatibility complex (MHC) class I A2 (HLA-A2) patients
Molecular Target Not applicable
Mechanism of ActionVaccine
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPreclinical
Standard IndicationGastric cancer
Indication DetailsTreat gastric cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today